← Patent-cliff monitor Loss of exclusivity October 2038 latest FDA-listed patent expiry
Company ASTRAZENECA AB
Drug detail Brand name BREZTRI AEROSPHERE Active ingredient BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE Strength 0.16MG/INH;0.0048MG/INH;0.018MG/INH Dosage form AEROSOL, METERED Route INHALATION Modality Small molecule FDA approval April 2026 Marketing status RX
Listed patents Patent Expires Type 11331442 October 2038 product 11833292 October 2038 product 8815258 March 2031 use U-4503 8324266 May 2030 use U-4503 9463161 May 2030 product 10716753 May 2030 product 9415009 May 2030 use U-4503 8703806 May 2030 use U-4503 8808713 May 2030 product
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.